Metabolomics Analysis for Defining Serum Biochemical Markers in Colorectal Cancer Patients with Qi Deficiency Syndrome or Yin Deficiency Syndrome

<div>Metabolite set enrichment analysis (MSEA) to capture the metabolomic diversity of serum samples of CRC patients with QD or YD compared with those with ND. (a) QD versus ND; (b) YD versus ND; (c) QD versus YD.</div>

Evidence-Based Complementary and Alternative Medicine

fig2

Figure 2

Figure 2: Metabolomics Analysis for Defining Serum Biochemical Markers in Colorectal Cancer Patients with Qi Deficiency Syndrome or Yin Deficiency Syndrome 

Figure 2 | Metabolomics Analysis for Defining Serum Biochemical Markers in Colorectal Cancer Patients with Qi Deficiency Syndrome or Yin Deficiency Syndrome 